Hi-Q Joined Hands with National Health Research Institutes (NHRI) to Participate Asia's Largest Biot

BIO Asia-Taiwan Exhibition 2021 is now taking place in Taipei. Hi-Q joined hands with National Health Research Institutes (NHRI) to participate this Asia's largest biotech networking event.

Dr. Chiou-Hwa Yuh from Institute of Molecular and Genetic Medicine of NHRI was invited to give presentation for her research findings on Oligo Fucoidan in the event. Dr. Yuh used zebrafish experimental platform to do a lot of research on Oligo Fucoidan. The research were published in high ranking SCI journal, demonstrating the multi-faceted development and application potential of fucoidan.


Cheng, C.-C., Yang, W.-Y., Hsiao, M.-C., Lin, K.-H., Lee, H.-W., & Yuh, C.-H. (2020). Transcriptomically revealed Oligo-Fucoidan enhances the immune system and protects hepatocytes via the ASGPR/STAT3/HNF4A Axis. Biomolecules, 10(6), 898.

Wu, S. Y., Yang, W. Y., Cheng, C. C., Lin, K. H., Sampurna, B. P., Chan, S. M., & Yuh, C. H. (2020). Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling. Clinical and Translational Medicine, 10(8).

Wu, S.-Y., Yang, W.-Y., Cheng, C.-C., Hsiao, M.-C., Tsai, S.-L., Lin, H.-K., Lin, K.-H., & Yuh, C.-H. (2020). Low molecular weight Fucoidan prevents radiation-induced fibrosis and secondary tumors in a zebrafish model. Cancers, 12(6), 1608.